ViroGates A/S VIRO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- DKK 7.38
- Day Range
- DKK 6.50–7.32
- 52-Week Range
- DKK 4.98–19.51
- Bid/Ask
- DKK 6.60 / DKK 7.30
- Market Cap
- DKK 41.89 Mil
- Volume/Avg
- 424 / 11,817
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.86
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 10
- Website
- https://www.virogates.com
Valuation
|
Metric
|
VIRO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.80 |
Price/Sales | 3.86 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VIRO
|
|---|---|
Quick Ratio | 8.56 |
Current Ratio | 10.84 |
Interest Coverage | −22.08 |
Quick Ratio
VIRO
Profitability
|
Metric
|
VIRO
|
|---|---|
Return on Assets (Normalized) | −69.79% |
Return on Equity (Normalized) | −96.02% |
Return on Invested Capital (Normalized) | −73.59% |
Return on Assets
VIRO
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Ylqcklkq | Ldbvy | $185.4 Bil | |
SYK
| Stryker Corp | Ptbsbvkbl | Mmlg | $127.7 Bil | |
BSX
| Boston Scientific Corp | Ztnwfwk | Lgldsq | $107.6 Bil | |
MDT
| Medtronic PLC | Mgqylvhjb | Rhsxg | $105.9 Bil | |
DXCM
| DexCom Inc | Phkxqrdlp | Xjqw | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Fwltmhyvx | Csyhts | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Fltxcblcs | Zfnb | $24.6 Bil | |
ALGN
| Align Technology Inc | Ptkcvyzc | Wdhgmqv | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Tptnwrmmb | Jrcdq | $18.7 Bil | |
PODD
| Insulet Corp | Wyvpzjvzl | Bbqhm | $11.6 Bil |